BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23968581)

  • 1. 3,3'-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells.
    Nicastro HL; Firestone GL; Bjeldanes LF
    J Nutr Biochem; 2013 Nov; 24(11):1882-8. PubMed ID: 23968581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
    Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
    Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory action of naphtho[1,2-b]furan-4,5-dione on hepatocyte growth factor-induced migration and invasion of MDA-MB-231 cells: mechanisms of action.
    Tsai PC; Chu CL; Tseng CH; Chen YL; Chang LS; Lin SR
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):716-26. PubMed ID: 24909202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
    Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells.
    Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
    Cell Biochem Funct; 2014 Aug; 32(6):485-95. PubMed ID: 24964901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.
    Hung CM; Kuo DH; Chou CH; Su YC; Ho CT; Way TD
    J Agric Food Chem; 2011 Sep; 59(17):9683-90. PubMed ID: 21806057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbacetin, a constituent of ephedrae herba, suppresses the HGF-induced motility of human breast cancer MDA-MB-231 cells by inhibiting c-Met and Akt phosphorylation.
    Hyuga S; Hyuga M; Yoshimura M; Amakura Y; Goda Y; Hanawa T
    Planta Med; 2013 Nov; 79(16):1525-30. PubMed ID: 24081687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
    Bigelow RL; Cardelli JA
    Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway.
    Du H; Zhang X; Zeng Y; Huang X; Chen H; Wang S; Wu J; Li Q; Zhu W; Li H; Liu T; Yu Q; Wu Y; Jie L
    Front Immunol; 2019; 10():1620. PubMed ID: 31396207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
    Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN reconstitution alters glioma responses to c-Met pathway inhibition.
    Goodwin CR; Lal B; Ho S; Woodard CL; Zhou X; Taeger A; Xia S; Laterra J
    Anticancer Drugs; 2011 Oct; 22(9):905-12. PubMed ID: 21654317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
    Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
    Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway.
    Lim CS; Walikonis RS
    Cell Signal; 2008 May; 20(5):825-35. PubMed ID: 18262389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells.
    Kim EJ; Eom SJ; Hong JE; Lee JY; Choi MS; Park JH
    Mol Cell Biochem; 2012 Jan; 359(1-2):431-40. PubMed ID: 21892609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
    Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB
    Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
    J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
    J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13
    Souid S; Elsayed HE; Ebrahim HY; Mohyeldin MM; Siddique AB; Karoui H; El Sayed KA; Essafi-Benkhadir K
    Mol Carcinog; 2018 Nov; 57(11):1507-1524. PubMed ID: 29978911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.